Mahon Paul A 的 Form 4/A 修正申報
修正United Therapeutics Corp（UTHR），2022/3/4 申報
- 申報編號
- 0001127602-22-008274
- 申報時間
- 2022/3/4
- 交易日
- 2022/1/6
- 申報延遲
- 57 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/1/6
這份申報列了 4 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $115.5 萬。交易後 57 天申報。
這份修正申報取代了 0001127602-22-001100（2022/1/6 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Mahon Paul ACIK 0001231589 | 高階主管（執行副總裁、法務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/1/6 | Common Stock | M行使選擇權處分 | −6,000 | $0.00 | $0 | 1,094 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2
This acquisition of common stock was inadvertently omitted from Table I on the original filing due to administrative error, although the corresponding option exercise was included on Table II. As a result, three subsequent Form 4 filings also incorrectly understated the reporting person's common stock balance by 6,000 shares (filed on January 20, 2022, February 3, 2022, and February 17, 2022).
- F3
This transaction was executed in multiple trades at prices ranging from $190.32 to $190.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $191.65 to $192.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $192.65 to $193.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The reporting person received two stock option grants, both with the same grant date and exercise price. Due to administrative error, previous option exercises occasionally were reported on Table II as having been drawn from the wrong tranche. This balance has been updated to correct these errors.